Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism TYK2 inhibitors(Tyrosine-protein kinase 2 inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Inflammatory Bowel Diseases | Preclinical | China | 01 Apr 2020 | |
| Psoriasis | Preclinical | China | 01 Apr 2020 | |
| Systemic Lupus Erythematosus | Preclinical | China | 01 Apr 2020 |





